AVTRAvantor, Inc.

$15.28

The financials

Avantor, Inc. by the numbers

Avantor, Inc. (AVTR) reported revenue of $1.58B in Q1 2026 (quarter ended Mar 31, 2026), up 0.0% from the same quarter a year earlier. That came with a gross margin of 32% and net income of $43M (2.7% of revenue). For the full year FY2025, revenue was $6.55B (−3.4% year on year) and net income −$530M. Its largest segment in Jun 2026 was VWR Distribution Services at $1.24B, 73% of the disclosed total, well ahead of Bioscience Medtech Products at 27%.

Avantor, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$1.58B$1.58B0.0%
Gross profit$501M$535M−6.4%
Operating income$100M$147M−32%
Net income$43M$65M−33%
Diluted EPS$0.06$0.09−33%
Revenue by segment, Jun 2026, as reported to the SEC
OperatingRevenueShare
VWR Distribution Services$1.24B73%
Bioscience Medtech Products$452M27%

Business Segments

Revenue split by operating segment, from SEC XBRL filings.

Latest period: Jun 2026Total $1.69B (+7.0%)
VWR Distribution Services grew +2.7% year on yearBioscience Medtech Products -5.1% year on year
  • VWR Distribution Services$1.24BQoQ +7.9%year on year +2.7%
  • Bioscience Medtech Products$451.8MQoQ +4.7%year on year -5.1%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-07-29, SEC EDGAR